Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Soares, Caroline Bitencourta | Daré, Leticia Rossia; b | Lima, Karine Ramiresa | Lopes, Luiza Freitasa | Santos, Alexandre Garcia dosa | Schimidt, Helen Lidianea | Carpes, Felipe Pivettaa | Lloret, Anac | Viña, Josec | Mello-Carpes, Pâmela Billiga; *
Affiliations: [a] Federal University of Pampa, campus Uruguaiana, Uruguaiana, RS, Brazil | [b] Federal University of Triangulo Mineiro, Uberaba, MG, Brazil | [c] University of Valencia, Valencia, Spain
Correspondence: [*] Correspondence to: Pâmela B. Mello-Carpes, Stress, Memory and Behavior Lab, Federal University of Pampa; BR 472 km 592 - Po box 118 - ZIP 97500-970, Uruguaiana, RS, Brazil. Tel.: +55 55 39110200, line 8091; E-mail: pamelacarpes@unipampa.edu.br.
Abstract: Background:Alzheimer’s disease (AD) is characterized by the accumulation of the amyloid-β peptide in the brain, leading to early oxidative stress and neurotoxicity. It has been suggested that physical exercise could be beneficial in preventing AD, but studies with multicomponent training are scanty. Objective:Verify the effects of multicomponent exercise training to prevent deficits in recognition memory related to Aβ neurotoxicity. Methods:We subjected Wistar rats to multicomponent training (including aerobic and anaerobic physical exercise and cognitive exercise) and then infused amyloid-β peptide into their hippocampus. Results:We show that long-term multicomponent training prevents the amyloid-β-associated neurotoxicity in the hippocampus. It reduces hippocampal lipid peroxidation, restores antioxidant capacity, and increases glutathione levels, finally preventing recognition memory deficits. Conclusion:Multicomponent training avoids memory deficits related to amyloid-β neurotoxicity on an animal model.
Keywords: Alzheimer’s disease, cognitive dysfunction, exercise therapy, oxidative stress
DOI: 10.3233/JAD-210424
Journal: Journal of Alzheimer's Disease, vol. 83, no. 1, pp. 143-154, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl